Plasma-fluphenazine concentrations after injection of long-acting esters.
作者信息
Curry S H, Whelpton R, de Schepper P J, Vranckx S, Schiff A A
出版信息
Lancet. 1978 Jun 3;1(8075):1217-8. doi: 10.1016/s0140-6736(78)91017-6.
PMID:77990
Abstract
摘要
相似文献
1
Plasma-fluphenazine concentrations after injection of long-acting esters.
Lancet. 1978 Jun 3;1(8075):1217-8. doi: 10.1016/s0140-6736(78)91017-6.
2
Unwanted effects of fluphenazine enanthate and decanoate.
Lancet. 1979 Feb 10;1(8111):331-2. doi: 10.1016/s0140-6736(79)90749-9.
3
Kinetics of fluphenazine after fluphenazine dihydrochloride, enanthate and decanoate administration to man.给人服用盐酸氟奋乃静、庚酸氟奋乃静和癸酸氟奋乃静后氟奋乃静的动力学
Br J Clin Pharmacol. 1979 Apr;7(4):325-31. doi: 10.1111/j.1365-2125.1979.tb00941.x.
4
The long-acting phenothiazines.
Arch Gen Psychiatry. 1975 Jul;32(7):893-900. doi: 10.1001/archpsyc.1975.01760250085009.
5
Low neuroleptic serum levels in patients receiving fluphenazine decanoate.接受癸酸氟奋乃静治疗的患者中抗精神病药物血清水平较低。
Am J Psychiatry. 1980 Jan;137(1):80-2. doi: 10.1176/ajp.137.1.80.
6
Fluphenazine decanoate and fluphenazine enanthate in the out-patient management of chronic schizophrenia.
Neuropsychobiology. 1978;4(6):360-5. doi: 10.1159/000117652.
7
Depot fluphenazine enanthate and decanoate: comparative rates of release in dogs.氟奋乃静庚酸酯和癸酸酯长效注射剂：犬体内的释放速率比较
J Pharm Pharmacol. 1975 Oct;27(10):791-2. doi: 10.1111/j.2042-7158.1975.tb09407.x.
8
Comparison of the incidence and severity of extrapyramidal side effects with fluphenazine enanthate and fluphenazine decanoate.
Am J Psychiatry. 1978 Dec;135(12):1539-42. doi: 10.1176/ajp.135.12.1539.
9
[Comparative study of the therapeutic effectiveness of mirenil prolongatum and moditen depot in the treatment of schizophrenia].[米氮平缓释片与莫迪替尼长效注射剂治疗精神分裂症的疗效对比研究]
Psychiatr Pol. 1976 Sep-Oct;10(5):479-85.
10
Animal model for investigation of fluphenazine kinetics after administration of long-acting esters.
Biopharm Drug Dispos. 1979 Oct-Dec;1(2):65-72. doi: 10.1002/bdd.2510010204.
引用本文的文献
1
Depot antipsychotic drugs. Place in therapy.长效抗精神病药物。在治疗中的应用。
Drugs. 1994 May;47(5):741-73. doi: 10.2165/00003495-199447050-00004.
2
Pharmacokinetic studies in volunteers of intravenous and oral cis (Z)-flupentixol and intramuscular cis (Z)-flupentixol decanoate in Viscoleo.在志愿者中进行的静脉注射和口服顺式（Z）-氟哌噻吨以及在Viscoleo中肌肉注射顺式（Z）-氟哌噻吨癸酸酯的药代动力学研究。
Eur J Clin Pharmacol. 1980 Oct;18(4):355-60. doi: 10.1007/BF00561395.
3
Variation in oro-facial tardive dyskinesia during depot antipsychotic drug treatment.长效抗精神病药物治疗期间口面部迟发性运动障碍的变化
Psychopharmacology (Berl). 1983;81(4):359-62. doi: 10.1007/BF00427579.
4
Plasma levels of fluphenazine during fluphenazine decanoate treatment in schizophrenia.精神分裂症患者癸酸氟奋乃静治疗期间的血浆氟奋乃静水平。
Psychopharmacology (Berl). 1985;87(1):55-8. doi: 10.1007/BF00431778.
5
Antipsychotic drugs. Clinical pharmacokinetics of potential candidates for plasma concentration monitoring.抗精神病药物。血浆浓度监测潜在候选药物的临床药代动力学。
Clin Pharmacokinet. 1987 Aug;13(2):65-90. doi: 10.2165/00003088-198713020-00001.
6
Clinical pharmacokinetics of the depot antipsychotics.长效抗精神病药物的临床药代动力学
Clin Pharmacokinet. 1985 Jul-Aug;10(4):315-33. doi: 10.2165/00003088-198510040-00003.
7
Pharmacokinetics of haloperidol and fluphenazine decanoates in chronic schizophrenia.氟哌啶醇和癸酸氟奋乃静在慢性精神分裂症中的药代动力学
Psychopharmacology (Berl). 1990;101(2):274-81. doi: 10.1007/BF02244140.
8
Plasma fluphenazine levels by radioimmunoassay in schizophrenic patients treated with depot injections of fluphenazine decanoate.采用放射免疫分析法测定接受氟奋乃静癸酸酯长效注射治疗的精神分裂症患者的血浆氟奋乃静水平。
Br J Clin Pharmacol. 1979 Dec;8(6):565-70. doi: 10.1111/j.1365-2125.1979.tb01045.x.
Zotero 插件